S C Cheng|R H Cheng - JoVE Visualize

Showing results (151-160 of 170) with videos related to

Pageof 17

Sort By:

Journal of Virology|March 1, 1993

Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibodyT J Smith, N H Olson, R H Cheng, et al.

Biomaterials|April 7, 2019

Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion cathetersQ Zhong, B C Yoon, M Aryal, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institutionP W Pisters, S R Patel, D G Varma, et al.

Journal of Hepatology|July 13, 2010

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWendy S C Cheng, Stuart K Roberts, Geoffrey McCaughan, et al.

Antiviral Therapy|April 20, 2012

Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patientsDarrell H G Crawford, Gregory J Dore, William Sievert, et al.

Cancer|February 1, 1984

Genetic predisposition to breast cancerH T Lynch, W A Albano, B S Danes, et al.

The Journal of Biological Chemistry|March 27, 1999

Cef1p is a component of the Prp19p-associated complex and essential for pre-mRNA splicingW Y Tsai, Y T Chow, H R Chen, et al.

Alimentary Pharmacology & Therapeutics|March 20, 2014

Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, V S Gainer, et al.

Clinical Genetics|May 10, 2002

Identification and characterization of mutations underlying Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA)G J Lee-Chen, S P Lin, M H Ko, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2015

A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasionC A Lago-Hernandez, H Feldman, E O'Donnell, et al.

Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:

Pageof 17

Journal of Virology|March 1, 1993

Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibodyT J Smith, N H Olson, R H Cheng, et al.

Biomaterials|April 7, 2019

Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion cathetersQ Zhong, B C Yoon, M Aryal, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institutionP W Pisters, S R Patel, D G Varma, et al.

Journal of Hepatology|July 13, 2010

Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWendy S C Cheng, Stuart K Roberts, Geoffrey McCaughan, et al.

Antiviral Therapy|April 20, 2012

Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patientsDarrell H G Crawford, Gregory J Dore, William Sievert, et al.

Cancer|February 1, 1984

Genetic predisposition to breast cancerH T Lynch, W A Albano, B S Danes, et al.

The Journal of Biological Chemistry|March 27, 1999

Cef1p is a component of the Prp19p-associated complex and essential for pre-mRNA splicingW Y Tsai, Y T Chow, H R Chen, et al.

Alimentary Pharmacology & Therapeutics|March 20, 2014

Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, V S Gainer, et al.

Clinical Genetics|May 10, 2002

Identification and characterization of mutations underlying Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA)G J Lee-Chen, S P Lin, M H Ko, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2015

A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasionC A Lago-Hernandez, H Feldman, E O'Donnell, et al.

Pageof 17